•
Dec 31, 2023

IGM Biosciences Q4 2023 Earnings Report

Total Revenue
$651K
Previous year: $372K
+75.0%
EPS
-$1.01
Previous year: -$1.19
-15.1%
Gross Profit
-$1.53M
Cash and Equivalents
$338M
Previous year: $121M
+179.0%
Free Cash Flow
-$49.5M
Previous year: -$40.6M
+22.0%
Total Assets
$423M
Previous year: $513M
-17.5%

IGM Biosciences

IGM Biosciences